The MIPEP gene helps mitochondria, the parts of cells that make energy, process certain proteins so cells can work normally. If the MIPEP gene does not work well, energy production can drop, especially in the heart, muscles, and brain. This gene plays an important role in tissues with high energy needs. People with two pathogenic variants may have a rare inherited condition linked to a thickened heart muscle, developmental delay, low muscle tone, and feeding or growth problems.
What is a gene?
A gene is a stretch of DNA that carries instructions cells use to make molecules or to regulate activities in the body. Some genes provide the code for proteins, which do much of the cell’s work. Others mainly guide when specific processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can also influence how you respond to food, stress, and medicines. For a deeper look at this subject, more information is available in the LearnHub.
Overview
MIPEPGene function
What if the gene works
The MIPEP gene helps activate certain proteins after they enter mitochondria, the parts of cells that make energy. This supports steady energy production, especially in tissues like the heart and muscles.
Risk
What if the gene does not work
More disruptive variants in the MIPEP gene can cause a mitochondrial condition marked by early cardiomyopathy, muscle weakness, lactic acidosis, and developmental delay; milder variants may lead to later onset or less severe features, sometimes including cataracts.
Treatment
What does that mean for your treatment
A pathogenic or loss-of-function variant in the MIPEP gene does not currently have a MIPEP-specific treatment or drug choice in clinical guidelines.
Conditions associated with MIPEP
Gene function
What if the gene works
Your cells rely on the MIPEP gene to help newly made proteins settle into mitochondria, the parts of cells that make most of your energy. It acts in a finishing step that gives certain proteins their final working form. This is a key part of how the MIPEP gene helps cells make energy day to day.
After some proteins enter mitochondria, MIPEP removes a small extra piece from them. This final trimming step helps those proteins reach a stable, usable form.
MIPEP works with other protein processing helpers inside mitochondria. This careful handoff helps imported proteins be prepared in the right order.
Many proteins finished by MIPEP are used in the mitochondrial system that turns food and oxygen into usable energy. This helps cells keep a steady energy supply for everyday work.
What is a variant?
Within a gene, a genetic variant is a small difference in the DNA sequence. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the MIPEP gene can make the protein unstable or reduce its enzyme activity, so mitochondria may not fully process some incoming proteins. This helps explain how MIPEP gene variants affect mitochondrial function at the cell level. Milder variants may leave some activity, while more severe variants, such as truncating or major splice changes, can leave very little or none. When the loss is greater, mitochondrial disease linked to MIPEP may appear earlier and be more pronounced.
How variants are linked to conditions
Among the conditions linked to variants in the MIPEP gene, the main one is a rare inherited energy production condition called combined oxidative phosphorylation deficiency 31. Reported features include cardiomyopathy, often a heart muscle pattern called left ventricular noncompaction, along with low muscle tone, developmental delay, feeding problems, and lactic acid buildup in the blood. Finding disease-causing variants in both copies of the MIPEP gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are widely found in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition points to a possible link rather than a certain diagnosis, especially when more than one gene and environmental factors are involved. In some cases, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the MIPEP gene. For many living with a disease-causing MIPEP change, risk is mainly tied to the genetic change itself, and personal concerns about symptoms or family risk are best discussed with a doctor or genetic counselor.
Inheritance of MIPEP variants
MIPEP gene variants linked to disease are inherited in an autosomal recessive pattern. This means a child usually inherits one altered copy of the MIPEP gene from each parent, while parents who carry one variant are often unaffected. When both parents are carriers, each pregnancy has a 25% chance of resulting in a child with the condition, a 50% chance of a child being a carrier, and a 25% chance of a child inheriting neither variant. In practical terms, MIPEP gene inheritance usually affects brothers and sisters in the same family rather than passing directly from an affected parent to every child.
What does my MIPEP result mean for my family?
Changes in the MIPEP gene are linked to a rare inherited condition that usually runs in families in a recessive pattern. For relatives, this mainly means parents may be carriers, brothers and sisters could also be affected or be carriers, and other family members may carry the same gene change without knowing it. The family impact can be especially relevant when planning children.
Genetic information
Genetic testing
How you find out about variants
MIPEP genetic testing checks your DNA from a blood, saliva, or cheek swab sample to look for variants in the MIPEP gene. It may be ordered as single gene testing or included in a broader panel or exome test. Results can show a disease causing variant, a benign variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Testing for the MIPEP gene may be considered when a baby or child has signs of a rare inherited condition that affects how the body makes energy, especially serious heart muscle problems along with low muscle tone, feeding trouble, delays, or seizures. It can also help when there is a family history of a MIPEP-related condition or an earlier child with similar symptoms.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but how much it can clarify depends on the condition and the specific type of variant. Over time, many factors shape how the body works, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can provide a clear answer. In areas such as medication response, genetic results may also help place personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. These differences are common and are one part of the bigger picture, along with age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medications. It studies links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medications, genes influence both how strongly a drug affects the body and how the body handles it. This information can support more informed, more personalized treatment decisions. To explore this topic further, you can learn more in the LearnHub.
Drugs influenced by the MIPEP gene
When should I seek medical advice?
There is not currently a broadly confirmed role for this gene in guiding medication response. If you have concerns about side effects, new symptoms, or how well a medicine is working, it is best to speak with your doctor or pharmacist.
History
MIPEP came into view through research on how mitochondria handle newly made proteins, especially studies from the late 20th century on mitochondrial peptidases. Scientists first recognized it in basic laboratory work, before it was tied to human disease. As medical science evolved, so did understanding of this gene. In the 2010s, reports of families with rare inherited mitochondrial and heart-related conditions helped establish the clinical importance of the MIPEP gene. Since then, improved genetic sequencing has made it easier to identify MIPEP variants and connect them with a clearer medical picture.